StageSeries B | Alive
Last Raised$15.65M | 1 yr ago
Missing: Weimi Bio-Tech's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Weimi Bio-Tech's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Weimi Bio-Tech
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Weimi Bio-Tech is included in 3 Expert Collections, including Medical Devices.
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Health Monitoring & Diagnostics
Companies developing technology to facilitate near-patient and point-of-care (POC) in vitro diagnostic testing. Companies tagged as #NearPatient&POCTesting
Weimi Bio-Tech Frequently Asked Questions (FAQ)
When was Weimi Bio-Tech founded?
Weimi Bio-Tech was founded in 2013.
Where is Weimi Bio-Tech's headquarters?
Weimi Bio-Tech's headquarters is located at No.502, Building G8, Southern China New Material Innovation Park, Kefeng Road No.31, Guangzhou.
What is Weimi Bio-Tech's latest funding round?
Weimi Bio-Tech's latest funding round is Series B.
How much did Weimi Bio-Tech raise?
Weimi Bio-Tech raised a total of $15.65M.
Who are the investors of Weimi Bio-Tech?
Investors of Weimi Bio-Tech include Med-Fine Capital, China Capital Investment Group, Chuangyu Investment and Jinhe Capital.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.